{"id":"W2045950562","doi":"10.1016/s1470-2045(09)70087-7","title":"Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II study","year":2009,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Institute for Health and Care Research; GlaxoSmithKline","keywords":"Medicine; Lapatinib; Internal medicine; Breast cancer; Response Evaluation Criteria in Solid Tumors; Oncology; Inflammatory breast cancer; Trastuzumab; Anthracycline; Cohort; Progressive disease; Metastatic breast cancer; Cancer; Refractory (planetary science); Taxane; Gastroenterology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001129398,0.000983396,0.001999106,0.0002305441,0.0002382898,0.0007972957,0.0005682329,0.0005301456,0.001179764],"category_scores_gemma":[0.0005742859,0.0003487635,0.001105625,0.0003869636,0.0004792193,0.0008678784,0.000280585,0.001812286,0.0003383507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007179599,"about_ca_system_score_gemma":0.0006449171,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00101698,"about_ca_topic_score_gemma":0.003548653,"domain_scores_codex":[0.9996965,0.0001376041,0.00001587679,0.00004459966,0.0000362967,0.00006917875],"domain_scores_gemma":[0.9995711,0.00009051512,0.0000798484,0.00005132779,0.00001856369,0.0001885319],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.727372,0.01213293,0.05953685,0.0004220803,0.002668259,0.0007472242,0.0002502394,0.004831706,0.02776591,0.0001810918,0.003481392,0.1606104],"study_design_scores_gemma":[0.4391226,0.2773725,0.26301,0.0000892429,0.003250708,0.001719214,0.0002985091,0.005621951,0.004550726,0.0005632799,0.004271751,0.0001294853],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975005,0.001118883,0.00009838455,0.0001292648,0.00002189767,0.0000769457,0.0003529521,0.00002043283,0.0006807657],"genre_scores_gemma":[0.9954777,0.001312767,0.0003544387,0.0002687315,0.00007269053,0.0001222589,0.001541928,0.00001438351,0.0008351294],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001999106,"threshold_uncertainty_score":0.005972922,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0591464160017507,"score_gpt":0.4011642093019165,"score_spread":0.3420177933001658,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}